Cargando…

A Modified Extraction Method of Circulating Free DNA for Epidermal Growth Factor Receptor Mutation Analysis

PURPOSE: Circulating free DNA (cfDNA) in plasma is promising to be a surrogate for tumor tissue DNA. However, not all epidermal growth factor receptor (EGFR) mutations in tumor tissue DNA has been detected in matched cfDNA, at least partly due to inefficient cfDNA extraction method. The purpose of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Haihua, Zhu, Zhong-Zheng, Lu, Yachao, Liu, Feng, Zhang, Wenying, Huang, Gang, Zhu, Guanshan, Jiang, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250323/ https://www.ncbi.nlm.nih.gov/pubmed/22187243 http://dx.doi.org/10.3349/ymj.2012.53.1.132

Ejemplares similares

Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer
por: Yunxia, Zuo, et al.
Publicado: (2010)

Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer
por: Yunxia, Zuo, et al.
Publicado: (2010)

Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib
por: Xu, Fei, et al.
Publicado: (2012)

Circulating-free DNA Mutation Associated with Response of Targeted Therapy in Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer
por: Ye, Qing, et al.
Publicado: (2017)

Sorting and gene mutation verification of circulating tumor cells of lung cancer with epidermal growth factor receptor peptide lipid magnetic spheres
por: Wang, Sheng‐guang, et al.
Publicado: (2020)

Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment
por: Uchida, Junji, et al.
Publicado: (2016)

Detection of clinically relevant epidermal growth factor receptor pathway mutations in circulating cell-free tumor DNA using next generation sequencing in squamous cell carcinoma lung
por: Govind, Kanakasetty Babu, et al.
Publicado: (2019)

TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib
por: Yu, Ruofei, et al.
Publicado: (2021)

Malignant Pleural Effusion Supernatants Are Substitutes for Metastatic Pleural Tumor Tissues in EGFR Mutation Test in Patients with Advanced Lung Adenocarcinoma
por: Liu, Dan, et al.
Publicado: (2014)

TP53 mutations on circulating cell-free DNA
por: Pantel, Klaus
Publicado: (2016)

Disease monitoring of epidermal growth factor receptor (EGFR)‐mutated non‐small‐cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNA
por: Li, Yan, et al.
Publicado: (2022)

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
por: Liu, Xiaoqing, et al.
Publicado: (2013)

Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies
por: Kato, Shumei, et al.
Publicado: (2019)

Cell Free Tumoral DNA Versus Paraffin Block Epidermal Growth Factor Receptor Mutation Detection in Patients with Non-Small Cell Lung Cancer
por: Mirtavoos-Mahyari, Hanifeh, et al.
Publicado: (2019)

Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation
por: Peng, Jianfeng, et al.
Publicado: (2021)

Efficacy of bronchoscopic biopsy for the detection of epidermal growth factor receptor mutations and anaplastic lymphoma kinase gene rearrangement in lung adenocarcinoma
por: Zhu, Pei, et al.
Publicado: (2015)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011)

Epidermal Growth Factor Receptor Mutations in Colorectal Cancer Patients
por: Oh, Bo-Young, et al.
Publicado: (2011)

Deep learning for predicting epidermal growth factor receptor mutations of non-small cell lung cancer on PET/CT images
por: Xiao, Zhenghui, et al.
Publicado: (2023)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients
por: Kitazono, Satoru, et al.
Publicado: (2019)

T790M mutations identified by circulating tumor DNA test in lung adenocarcinoma patients who progressed on first-line epidermal growth factor receptor-tyrosine kinase inhibitors
por: Merinda, Vinodini, et al.
Publicado: (2020)

Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)
por: Kimura, H, et al.
Publicado: (2007)

Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients
por: Zhang, Qing, et al.
Publicado: (2015)

Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells
por: Gruijs, Mandy, et al.
Publicado: (2022)

Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?: A meta-analysis
por: Liu, Yafang, et al.
Publicado: (2016)

Pitfalls in diagnosis with the use of circulating tumor‐derived epidermal growth factor receptor mutations in lung cancer harboring pretreatment T790M
por: Ogawara, Daiki, et al.
Publicado: (2017)

Analyzing microsatellite instability and gene mutation in circulating cell-free DNA to monitor colorectal cancer progression
por: Fu, Yun, et al.
Publicado: (2021)

Detection of epidermal growth factor receptor mutation in lung cancer by droplet digital polymerase chain reaction
por: Xu, Qing, et al.
Publicado: (2015)

p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
por: Yoon, K. S., et al.
Publicado: (2001)

Adenocarcinoma of the lung with positive epidermal growth factor receptor mutation in pregnancy
por: Amanda, Gina, et al.
Publicado: (2017)

CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation
por: Zhao, Jing, et al.
Publicado: (2017)

Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples
por: Morgan, Shethah R., et al.
Publicado: (2012)

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
por: Kim, Hye-Ryoun, et al.
Publicado: (2013)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics
por: Jiao, Jingjing, et al.
Publicado: (2021)

Multigene PCR using both cfDNA and cfRNA in the supernatant of pleural effusion achieves accurate and rapid detection of mutations and fusions of driver genes in patients with advanced NSCLC
por: Chen, Xuejing, et al.
Publicado: (2021)

Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti–Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer
por: Topham, James T., et al.
Publicado: (2023)

New prognostic system specific for epidermal growth factor receptor-mutated lung cancer brain metastasis
por: Zhu, Li-Hua, et al.
Publicado: (2023)

A continuous method for the large-scale extraction of plasmid DNA by modified boiling lysis
por: Zhu, Kaichun, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ldnisv5llqronlcvbvmreheba4